Todd C. Davis - Jun 9, 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
By: /s/ Andrew Reardon For: Todd C. Davis
Stock symbol
LGND
Transactions as of
Jun 9, 2023
Transactions value $
-$30,979
Form type
4
Date filed
6/13/2023, 06:52 PM
Previous filing
Feb 27, 2023
Next filing
Sep 25, 2023
SEC
View on sec.gov

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
F2 The number reflected in Column 5 reconciles the total number of shares beneficially held following the transactions reported herein.